EP1460997A4 - Verfahren zur reinigung von levofloxacin - Google Patents

Verfahren zur reinigung von levofloxacin

Info

Publication number
EP1460997A4
EP1460997A4 EP02791339A EP02791339A EP1460997A4 EP 1460997 A4 EP1460997 A4 EP 1460997A4 EP 02791339 A EP02791339 A EP 02791339A EP 02791339 A EP02791339 A EP 02791339A EP 1460997 A4 EP1460997 A4 EP 1460997A4
Authority
EP
European Patent Office
Prior art keywords
levofloxacin
purification
methods
purified
antioxidant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02791339A
Other languages
English (en)
French (fr)
Other versions
EP1460997A2 (de
Inventor
Valerie Niddam-Hildesheim
Neomi Gershon
Eduard Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/263,192 external-priority patent/US7629458B2/en
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of EP1460997A2 publication Critical patent/EP1460997A2/de
Publication of EP1460997A4 publication Critical patent/EP1460997A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
EP02791339A 2001-11-29 2002-11-27 Verfahren zur reinigung von levofloxacin Withdrawn EP1460997A4 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US33431601P 2001-11-29 2001-11-29
US334316P 2001-11-29
US35493902P 2002-02-11 2002-02-11
US354939P 2002-02-11
US26296502A 2002-10-03 2002-10-03
US10/263,192 US7629458B2 (en) 2001-10-03 2002-10-03 Preparation of levofloxacin and hemihydrate thereof
US263192 2002-10-03
US262965 2002-10-03
PCT/US2002/038182 WO2003045329A2 (en) 2001-11-29 2002-11-27 Methods for the purification of levofloxacin

Publications (2)

Publication Number Publication Date
EP1460997A2 EP1460997A2 (de) 2004-09-29
EP1460997A4 true EP1460997A4 (de) 2005-06-15

Family

ID=31892240

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02791339A Withdrawn EP1460997A4 (de) 2001-11-29 2002-11-27 Verfahren zur reinigung von levofloxacin

Country Status (13)

Country Link
EP (1) EP1460997A4 (de)
JP (3) JP2005527484A (de)
CN (1) CN1596256A (de)
AU (1) AU2002365416A1 (de)
CA (1) CA2466860A1 (de)
HR (1) HRP20040546A2 (de)
HU (1) HUP0500285A3 (de)
IL (1) IL162172A0 (de)
IS (1) IS7288A (de)
MX (1) MXPA04005196A (de)
NO (1) NO20042731L (de)
PL (1) PL374558A1 (de)
WO (1) WO2003045329A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629458B2 (en) 2001-10-03 2009-12-08 Teva Pharmaceutical Industries Ltd. Preparation of levofloxacin and hemihydrate thereof
AU2003285625A1 (en) * 2002-12-16 2004-07-09 Ranbaxy Laboratories Limited Pure levofloxacin hemihydrate and processes for preparation thereof
KR100704641B1 (ko) * 2004-07-21 2007-04-06 주식회사유한양행 고순도의 레보플록사신 제조방법
JP2006273718A (ja) * 2005-03-28 2006-10-12 Shiono Chemical Co Ltd レボフロキサシン・１／２水和物の製法
CN1321121C (zh) * 2005-04-21 2007-06-13 浙江医药股份有限公司新昌制药厂 左氧氟沙星制备及后处理方法
US7964723B2 (en) * 2008-08-02 2011-06-21 Apeloa-Kangyu And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate
CN102070650B (zh) * 2011-01-28 2012-06-27 山东省药品检验所 左氧氟沙星-n-氧化物的制备方法
US20120251685A1 (en) * 2011-04-04 2012-10-04 Martek Biosciences Corporation Oil-in-Water Emulsions Comprising a Polyunsaturated Fatty Acid and Methods of Making the Same
CN105823851A (zh) * 2015-12-15 2016-08-03 浙江海洋学院 一种检测海水中氧氟沙星对映体的方法
CN108218892A (zh) * 2018-03-16 2018-06-29 乐山职业技术学院 一种左氧氟沙星的纯化方法
CN112174981A (zh) * 2020-11-03 2021-01-05 深圳市祥根生物科技有限公司 一种左氧氟沙星脱氟杂质的制备方法
CN114507242B (zh) * 2022-01-26 2023-05-19 上虞京新药业有限公司 高光学纯度左氧氟沙星的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003028665A2 (en) * 2001-10-03 2003-04-10 Teva Pharmaceutical Industries Ltd. Methods for the purification of levofloxacin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK170473B1 (da) * 1985-06-20 1995-09-11 Daiichi Seiyaku Co S(-)-pyridobenzoxazinforbindelser
US5237060A (en) * 1985-12-10 1993-08-17 Bayer Aktiengesellschaft Process of preparing enantiomerically pure 1,8-bridged 4-quinolone-3-carboxylic acids
TW208013B (de) * 1990-03-01 1993-06-21 Daiichi Co Ltd
JPH07501835A (ja) * 1992-10-07 1995-02-23 デリバドス・デル・エチロ・ソシエダッド・アノニマ オフロキサジン，レボフロキサジン及び誘導体の合成に使用されるベンゾキサジンの製造法
KR0125115B1 (ko) * 1994-03-22 1997-12-05 김은영 (-)피페라진 벤즈옥사진 유도체의 제조방법
KR100309871B1 (ko) * 1999-02-24 2001-10-29 윤종용 (-)피리도벤즈옥사진 카르복실산 유도체의 제조방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003028665A2 (en) * 2001-10-03 2003-04-10 Teva Pharmaceutical Industries Ltd. Methods for the purification of levofloxacin
WO2003028664A2 (en) * 2001-10-03 2003-04-10 Teva Pharmaceutical Industries Ltd. Preparation of levofloxacin and forms thereof

Also Published As

Publication number Publication date
HUP0500285A2 (hu) 2005-06-28
JP2006219496A (ja) 2006-08-24
IL162172A0 (en) 2005-11-20
IS7288A (is) 2004-06-21
WO2003045329A3 (en) 2004-02-19
CN1596256A (zh) 2005-03-16
AU2002365416A1 (en) 2003-06-10
NO20042731L (no) 2004-06-29
EP1460997A2 (de) 2004-09-29
CA2466860A1 (en) 2003-06-05
JP2005527484A (ja) 2005-09-15
PL374558A1 (en) 2005-10-31
MXPA04005196A (es) 2005-11-23
JP2008007517A (ja) 2008-01-17
HUP0500285A3 (en) 2009-03-30
WO2003045329A2 (en) 2003-06-05
HRP20040546A2 (en) 2004-10-31

Similar Documents

Publication Publication Date Title
WO2003028665A3 (en) Methods for the purification of levofloxacin
WO2003045329A3 (en) Methods for the purification of levofloxacin
DK1518859T3 (da) Fremgangsmåde til oprensning af thiophener
EP1467735A4 (de) Polymorphe von clopidogrel-hydrogensulfat
FI109023B (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
AU2002341989A1 (en) Process to produce derivatives from uk-2a derivatives
WO2001082909A3 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
WO2004035800A3 (en) Intermediate cefdinir salts
WO2002102787A3 (en) Novel sulfonic acid derivatives
AU2003282383A1 (en) A process for the preparation of high purity escitalopram
BRPI0400375B8 (pt) processo para remover vírus em soluções de fibrinogênio para aplicação terapêutica
NO20051047L (no) Fremgangsmate og mellomprodukter for fremstilling av tienopyrrolderivater
CA2259339A1 (en) Crystals of vitamin d derivatives and process for the preparation thereof
WO2002092602A3 (en) PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-[2,3-f] QUINOLINE
WO2003011228A3 (en) Purification and crystalline forms of zaleplon
WO2005005461A3 (fr) Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
TW200517368A (en) Process
EP2070931A3 (de) Herstellungsverfahren für 2-Fluoradenin
HK1039932A1 (zh) 使用馬杜拉二氮雜萘衍生物抑制前炎性細胞質變化
AU6594900A (en) Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof andagents
WO2002094773A3 (en) Process for the isolation of crystalline imipenem
AU2003219423A1 (en) Process for the isolation of high purity crystalline citalopram base
AU2002351074A1 (en) Process for the separation of racemic mixtures
WO2003057665A1 (en) Process for producing crystal of benzenesulfonamide derivative, and novel crystal of intermediate therefor and process for producing the same
AU2003219507A1 (en) Process for the preparation of highly pure torsemide

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040628

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07D 413/04 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050428

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07D 221:00 J

Ipc: 7C 07D 265:00 J

Ipc: 7C 07D 498/06 J

Ipc: 7C 07D 498/06 A

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RTI1 Title (correction)

Free format text: PROCESS FOR THE PREPARATION OF LEVOFLOXACIN HEMIHYDRATE

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 498/06 20060101AFI20100419BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100915